JP2025148482A5 - - Google Patents

Info

Publication number
JP2025148482A5
JP2025148482A5 JP2025117223A JP2025117223A JP2025148482A5 JP 2025148482 A5 JP2025148482 A5 JP 2025148482A5 JP 2025117223 A JP2025117223 A JP 2025117223A JP 2025117223 A JP2025117223 A JP 2025117223A JP 2025148482 A5 JP2025148482 A5 JP 2025148482A5
Authority
JP
Japan
Prior art keywords
compound
composition
optionally substituted
independently selected
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025117223A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025148482A (ja
Filing date
Publication date
Priority claimed from PCT/US2020/059201 external-priority patent/WO2021092240A1/en
Application filed filed Critical
Publication of JP2025148482A publication Critical patent/JP2025148482A/ja
Publication of JP2025148482A5 publication Critical patent/JP2025148482A5/ja
Pending legal-status Critical Current

Links

JP2025117223A 2019-11-05 2025-07-11 炎症性障害を治療するためのMrgprX2アンタゴニスト Pending JP2025148482A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201962931183P 2019-11-05 2019-11-05
US62/931,183 2019-11-05
US201962931698P 2019-11-06 2019-11-06
US62/931,698 2019-11-06
US202063046461P 2020-06-30 2020-06-30
US63/046,461 2020-06-30
PCT/US2020/059201 WO2021092240A1 (en) 2019-11-05 2020-11-05 Mrgprx2 antagonists for the treatment of inflammatory disorders
JP2022526326A JP7712922B2 (ja) 2019-11-05 2020-11-05 炎症性障害を治療するためのMrgprX2アンタゴニスト

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022526326A Division JP7712922B2 (ja) 2019-11-05 2020-11-05 炎症性障害を治療するためのMrgprX2アンタゴニスト

Publications (2)

Publication Number Publication Date
JP2025148482A JP2025148482A (ja) 2025-10-07
JP2025148482A5 true JP2025148482A5 (https=) 2025-10-15

Family

ID=73646519

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022526326A Active JP7712922B2 (ja) 2019-11-05 2020-11-05 炎症性障害を治療するためのMrgprX2アンタゴニスト
JP2025117223A Pending JP2025148482A (ja) 2019-11-05 2025-07-11 炎症性障害を治療するためのMrgprX2アンタゴニスト

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022526326A Active JP7712922B2 (ja) 2019-11-05 2020-11-05 炎症性障害を治療するためのMrgprX2アンタゴニスト

Country Status (8)

Country Link
US (3) US20230029266A1 (https=)
EP (1) EP4054554A1 (https=)
JP (2) JP7712922B2 (https=)
CN (1) CN114845709B (https=)
AU (1) AU2020380395A1 (https=)
CA (1) CA3159766A1 (https=)
IL (1) IL292690A (https=)
WO (1) WO2021092240A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019533022A (ja) 2016-10-24 2019-11-14 ユマニティ セラピューティクス,インコーポレーテッド 化合物及びその使用
EP3566055B1 (en) 2017-01-06 2025-03-12 Janssen Pharmaceutica NV Scd inhibitor for the treatment of neurological disorders
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
WO2019183587A1 (en) 2018-03-23 2019-09-26 Yumanity Therapeutics, Inc. Compounds and uses thereof
WO2020154571A1 (en) 2019-01-24 2020-07-30 Yumanity Therapeutics, Inc. Compounds and uses thereof
WO2021092240A1 (en) 2019-11-05 2021-05-14 Dermira, Inc. Mrgprx2 antagonists for the treatment of inflammatory disorders
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
TWI904906B (zh) 2020-08-24 2025-11-11 美商達薩瑪治療公司 Sarm1之抑制劑
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors
WO2023111996A1 (en) 2021-12-17 2023-06-22 Reglagene Holding, Inc. Compositions and methods of making and using small molecules in the treatment of cancer
US12215102B2 (en) 2023-02-28 2025-02-04 Reglagene, Inc. Compositions and methods for making and using small molecules for tubulin-targeted therapy in the treatment of cancers and related conditions
WO2025002360A1 (zh) * 2023-06-30 2025-01-02 北京普祺医药科技股份有限公司 一种mrgprx2拮抗剂、药物组合物以及其用途
WO2025042736A1 (en) 2023-08-18 2025-02-27 Incyte Corporation Bicyclic heterocycles as mrgprx2 antagonists
WO2025066935A1 (en) * 2023-09-28 2025-04-03 Hepaitech (Beijing) Biopharma Technology Co., Ltd. Compounds, compositions and methods thereof
WO2025130765A1 (en) * 2023-12-18 2025-06-26 Hepaitech (Beijing) Biopharma Technology Co., Ltd. Compounds, compositions and methods thereof
WO2025160430A1 (en) 2024-01-25 2025-07-31 Incyte Corporation Bicyclic heterocycles as mrgprx2 antagonists
KR20250121245A (ko) * 2024-02-02 2025-08-12 삼진제약주식회사 MRGPRX2 (Mas-related G-protein coupled receptor member X2) 길항제로서 신규 화합물 및 이를 포함하는 약학적 조성물
WO2025222040A1 (en) 2024-04-19 2025-10-23 Escient Pharmaceuticals, Inc. Mrgprx2 modulators for use in treating mrgprx2 dependent conditions in subjects with low ige
JP2026009006A (ja) * 2024-07-01 2026-01-19 日本たばこ産業株式会社 ピリダジノン化合物及びその医薬用途
WO2026035726A1 (en) * 2024-08-07 2026-02-12 Arcus Biosciences, Inc. Piperidylurea compounds and methods of use thereof
US12612396B1 (en) * 2024-11-20 2026-04-28 Dewpoint Therapeutics, Inc. Modulators of beta catenin and uses thereof

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493555A (en) 1966-03-23 1970-02-03 Nepera Chem Co Inc 3-phenylazo-2,6-pyridyl dicyclopropane-carboxamide
US4152442A (en) 1975-06-05 1979-05-01 Lilly Industries Limited Certain acylamino-oxa (or thia) diazoles in treatment of hypersensitivity conditions
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4328245A (en) 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
JPH0717589B2 (ja) * 1990-01-22 1995-03-01 ファイザー製薬株式会社 新規1,3―ジカルボニル化合物およびその組成物
CH681383A5 (https=) 1990-04-11 1993-03-15 Alusuisse Lonza Services Ag
US5290943A (en) 1991-02-21 1994-03-01 Ichikawa Gosei Chemical Co., Ltd. Method of producing 2-acyl amino 5-halogenopyridine compounds
JPH05201981A (ja) 1991-08-06 1993-08-10 Ichikawa Gosei Kagaku Kk 2−アミノ−3−ニトロ−5−ハロゲノピリジン類の製造方法
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
EP1534273A4 (en) 2002-07-18 2007-08-22 Bristol Myers Squibb Co MODULATORS OF THE GLUCOCORTICOID RECEPTOR AND METHOD
WO2004069160A2 (en) 2003-01-28 2004-08-19 Smithkline Beecham Corporation Chemical compounds
JP2006522744A (ja) 2003-04-11 2006-10-05 ノボ ノルディスク アクティーゼルスカブ グルココルチコイド受容体アゴニスト療法に伴う副作用を最小化するための、11β−ヒドロキシステロイドデヒドロゲナーゼ1型阻害剤およびグルココルチコイド受容体アゴニストを使用する併用療法
ZA200602755B (en) 2003-09-06 2007-06-27 Vertex Pharma Modulators of ATP-binding cassette transporters
EP1696915A1 (en) 2003-12-19 2006-09-06 Pfizer, Inc. Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
JP2008510726A (ja) * 2004-08-20 2008-04-10 エントレメッド インコーポレイテッド プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法
CN1736989A (zh) 2004-08-20 2006-02-22 中国科学院大连化学物理研究所 一种杂环菊酯类化合物及其在除草杀菌方面的应用
KR20080063865A (ko) 2005-11-28 2008-07-07 에프. 호프만-라 로슈 아게 다이아실글리세롤 아실전이효소(dgat)의 저해제
WO2007086584A1 (ja) * 2006-01-30 2007-08-02 Meiji Seika Kaisha, Ltd. 新規FabKおよびFabI/K阻害剤
AU2007230911A1 (en) 2006-03-23 2007-10-04 Synta Pharmaceuticals Corp. Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
CA2691214A1 (en) * 2006-06-09 2007-12-21 Kemia, Inc. Therapy using cytokine inhibitors
WO2008063625A2 (en) 2006-11-20 2008-05-29 Adolor Corporation Pyridine compounds and methods of their use
EP2125799A1 (en) * 2007-02-28 2009-12-02 Smithkline Beecham Corporation Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
MX2010013705A (es) 2008-06-13 2011-02-25 Bayer Cropscience Ag Nuevas amidas y tioamidas heteroaromaticas como plaguicidas.
WO2011074658A1 (ja) 2009-12-18 2011-06-23 田辺三菱製薬株式会社 新規抗血小板薬
US20110190269A1 (en) 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
EP2545037A1 (en) 2010-03-10 2013-01-16 Ingenium Pharmaceuticals GmbH Inhibitors of protein kinases
DE102010012594A1 (de) * 2010-03-23 2011-09-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Thiazolderivaten
KR101688978B1 (ko) * 2010-08-18 2016-12-26 중앙대학교 산학협력단 신규한 2-아미노 티아졸 유도체 및 이를 포함하는 항암용 조성물
PT2673285T (pt) 2010-12-09 2017-10-19 Wockhardt Ltd Resumo
DE102011083271A1 (de) * 2011-09-23 2013-03-28 Beiersdorf Ag Aromatische Amidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Aromatischen Amidothiazolen
CA2850551A1 (en) 2011-09-30 2013-04-04 Endo Pharmaceuticals Inc. Pyridine derivatives
FR2982261B1 (fr) 2011-11-04 2014-06-13 Galderma Res & Dev Nouveaux amides, et leur utilisation pharmaceutique ou cosmetique
WO2014040243A1 (zh) * 2012-09-12 2014-03-20 湖南有色凯铂生物药业有限公司 N-取代苯基-n'-取代杂环脲类化合物及其作为抗癌药物的应用
US9040712B2 (en) * 2013-01-23 2015-05-26 Novartis Ag Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
ES2670517T3 (es) 2013-01-30 2018-05-30 Sumitomo Chemical Company, Limited Compuesto de amida, un agente de control de plagas de artrópodos y un método para controlar las plagas de artrópodos
WO2014125426A1 (en) 2013-02-15 2014-08-21 Aurigene Discovery Technologies Limited Trisubstituted heterocyclic derivatives as ror gamma modulators
EP3444251B1 (en) 2013-12-11 2023-06-07 Biogen MA Inc. Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
US9758505B2 (en) 2014-02-12 2017-09-12 Iteos Therapeutics 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
CN104876878B (zh) * 2014-02-27 2018-04-27 中国科学院广州生物医药与健康研究院 5-芳基酚-2烷基取代脲苯并咪唑类化合物及其应用
GB201416754D0 (en) 2014-09-23 2014-11-05 Mission Therapeutics Ltd Novel compounds
US10253023B2 (en) 2014-10-06 2019-04-09 Merck Patent Gmbh Heteroaryl compounds as BTK inhibitors and uses thereof
WO2016160938A1 (en) * 2015-04-02 2016-10-06 Abbvie Inc. N-(1,3-thiazol-2-yl)pyrimidine-5-carboxamides as trpv3 modulators
WO2017064068A1 (en) * 2015-10-14 2017-04-20 Almirall, S.A. New trpa1 antagonists
AR106679A1 (es) 2015-11-13 2018-02-07 Basf Se Oxadiazoles sustituidos para combatir hongos fitopatógenos
CN105924387A (zh) 2016-04-28 2016-09-07 西安交通大学 一种具有抗肿瘤活性的双芳基脲化合物及其制备方法和应用
IL266181B2 (en) * 2016-11-03 2024-04-01 Corvus Pharmaceuticals Inc Compounds and methods for modulating interleukin-2-inducible t-cell kinase
WO2018114783A1 (en) 2016-12-23 2018-06-28 Bayer Pharma Aktiengesellschaft Tetrazole containing compounds
CA3055194A1 (en) 2017-03-02 2018-09-07 Assembly Biosciences, Inc. Cyclic sulfamide compounds and methods of using same
UY37957A (es) * 2017-11-02 2019-05-31 Abbvie Inc Moduladores de la vía de estrés integrada
EP3498694A1 (en) 2017-12-12 2019-06-19 Medibiofarma, S.L. New benzamide derivatives as ppar-gamma modulators
CN108451967B (zh) * 2018-06-04 2020-06-19 西安交通大学 克拉霉素在制备抗类过敏反应药物中的应用
CN108619183A (zh) * 2018-06-04 2018-10-09 西安交通大学 一种白芷中香豆素类化合物的简单提取方法及其应用
WO2021092240A1 (en) 2019-11-05 2021-05-14 Dermira, Inc. Mrgprx2 antagonists for the treatment of inflammatory disorders
CN114901280B (zh) 2019-11-05 2025-05-27 德米拉公司 MrgprX2拮抗剂及其用途

Similar Documents

Publication Publication Date Title
JP2025148482A5 (https=)
JP2022554389A5 (https=)
JP2022554392A5 (https=)
JP2022554391A5 (https=)
CN1902196B (zh) 噻唑衍生物
JP2024023271A (ja) 化合物
US20130102607A1 (en) Ureido-pyrazole derivatives for use in the treatment of rhinovirus infections
CN117561061A (zh) 用于治疗肺癌的3-(咪唑-4-基)-4-(氨基)-苯磺酰胺tead抑制剂与egfr抑制剂和/或mek抑制剂的组合
KR102616949B1 (ko) 고리형 구조를 갖는 화합물
JP2022500379A5 (https=)
JP2009542723A5 (https=)
KR20080072933A (ko) C-글리코시드 유도체 또는 이의 염, 및 이를 포함하는의약 조성물
CN104144913A (zh) B型肝炎抗病毒剂
JP2005518447A5 (https=)
RU2004131680A (ru) Производные бензофурана
TW201803869A (zh) 作為RORγT調節劑之6-胺基吡啶-3-基噻唑
KR20140059774A (ko) 전압-게이팅 나트륨 채널 차단제
CN111670189A (zh) 对rsv具有活性的环烷基取代的吡唑并嘧啶
JP6219817B2 (ja) フェニルキサンテン誘導体
JP4045099B2 (ja) 20−hete産生酵素阻害剤
CN110938068B (zh) N-(吗啉-2-基甲基)酰胺衍生物及其用途
JP6397912B2 (ja) Rsv抗ウイルス化合物としての置換ピリジンピペラジニルアナログ
JP4803181B2 (ja) キナゾリン誘導体及び医薬
WO2021218992A1 (zh) 取代的吡咯烷类化合物及其在药物中的应用
CN114846004A (zh) 新型抗疟药